Burrows Scott L bought SYRE
March 3, 2026 · Form 4 insider transaction
Burrows Scott L bought 2,500 shares of Spyre Therapeutics, Inc. at $14.50 per share, a transaction worth $36.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$14.50
Total value
$36.3K
InsiderBurrows Scott L
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 3, 2026
Filing dateMarch 3, 2026
Shares owned after100,494
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.